You are here: Industry Insights > ANDA

News List

ANI Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules americanpharmaceuticalreview
March 04, 2020
ANI Pharmaceuticals has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
Glenmark Receives ANDA Approval for Pimecrolimus Cream, 1% americanpharmaceuticalreview
September 03, 2019
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (FDA) for Pimecrolimus Cream, 1%, a generic version of Elidel® Cream, 1%, of Bausch Health US.
A Review of U.S. ANDA Approvals Received by Chinese Pharmaceutical Enterprises in the First Half of 2019 PharmaSources/Caicai
July 16, 2019
41 Approval Numbers, Multiple Blockbuster Varieties
SunGen Pharma Receives Sixth ANDA Approval from FDA contractpharma
July 10, 2019
Methylprednisolone approved for treatment of arthritis, allergic reactions, and immune system disorders.
Glenmark receives ANDA approval for Ranolazine Extended-Release Tablets biospectrumasia
July 09, 2019
It is a generic version of Ranexa® Extended-Release Tablets, 500 mg and 1,000 mg, of Gilead Sciences, Inc.
FDA Announces Public Health Emergency Prioritization of ANDAs for Opioid Overdose americanpharmaceuticalreview
July 09, 2019
In accordance with the Center for Drug Evaluation and Researchs Manual of Policies and Procedures (MAPP) 5240.3,Prioriti
Glenmark receives ANDA approval for Dipyridamole capsules expressbpd
May 29, 2019
Aspirin and extended-release Dipyridamole capsules, 25 mg/200 mg, is a generic version of Aggrenox Capsules, 25 mg/200 mg, of Boehringer Ingelheim
Amerigen Announces FDA Approval for Generic Penicillamine 250 mg Capsules americanpharmaceuticalreview
May 09, 2019
Amerigen announced that the company's Abbreviated New Drug Application (ANDA) for Penicillamine Capsules USP 250 mg has received final approval from the U.S. Food and Drug Administration (FDA).
Dr. Reddy's Laboratories Announces Acquisition of ANDA Portfolio firstwordpharma
April 15, 2019
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as ……
Glenmark receives ANDA approval for Clindamycin and Benzoyl Peroxide Gel, 1%|5% biospectrumasia
March 15, 2019
It is a generic version of BenzaClin® Gel, 1%|5%, of Valeant Bermuda

Previous page 1 2 3 4 5 6 7 Next page